MedTrace Logo

Ovarian Tissue Cryopreservation in the Setting of Gender-affirming Therapy

NCT05863676 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2025-08-07

No results posted yet for this study

Summary

The goal of this study is to learn about fertility preservation in the gender-diverse community. The main objectives it aims to understand are to:

1. To optimize techniques for cryopreservation of ovarian tissues, including determining efficacy of cryopreservation techniques.
2. To investigate factors affecting ovarian tissue and follicles, such as previous treatment with leuprolide acetate, or hormone therapy

Conditions

  • Gender Dysphoria
  • Transgender

Interventions

PROCEDURE

Oophorectomy

Ovary will be removed for fertility preservation.

DIAGNOSTIC_TEST

Infectious Disease Testing

Infectious Disease Testing will be done on participants.

Sponsors & Collaborators

  • University of Pittsburgh

    lead OTHER

Principal Investigators

  • Kyle Orwig, PhD · University of Pittsburgh/ University of Pittsburgh Medical Center

Eligibility

Min Age
9 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-14
Primary Completion
2030-07-31
Completion
2030-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05863676 on ClinicalTrials.gov